STOCK TITAN

Nutex Health Inc. (NUTX) director gains 603 shares through restricted stock unit conversion

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. director Cheryl Yvonne Grenas reported the exercise and conversion of restricted stock units into 603 shares of common stock on July 31, 2026. The units convert into common stock on a one-for-one basis and were recorded at $0.0000 per share, bringing her direct holdings to 670 shares after the transaction.

Positive

  • None.

Negative

  • None.
Insider Grenas Cheryl Yvonne
Role Director
Type Security Shares Price Value
Exercise Common Stock F1 603 $0.00 $0.00
Holdings After Transaction: Common Stock — 670 shares (Direct)
Footnotes (1)
  1. F1. Restricted stock units convert into common stock on a one-for-one basis.
Shares acquired 603 shares Common stock received from restricted stock unit conversion on July 31, 2026
Price per share $0.0000 Stated price for 603 common shares received from RSU conversion
Shares owned after transaction 670 shares Total direct Nutex Health common stock held by Cheryl Yvonne Grenas after the transaction
restricted stock units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Form 4 regulatory
"as disclosed in the Form 4 insider report"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Nutex Health (NUTX) report for Cheryl Yvonne Grenas?

Cheryl Yvonne Grenas, a director of Nutex Health, reported acquiring 603 shares of common stock through the exercise and conversion of restricted stock units. These units convert into common stock on a one-for-one basis, increasing her direct holdings to 670 shares.

How many Nutex Health (NUTX) shares does Cheryl Yvonne Grenas hold after this Form 4?

Following the reported transaction, Cheryl Yvonne Grenas directly holds 670 shares of Nutex Health common stock. This reflects the addition of 603 shares acquired via restricted stock unit conversion, as disclosed in the Form 4 insider report.

What was the price per share for the Nutex Health (NUTX) shares acquired by Cheryl Yvonne Grenas?

The 603 Nutex Health shares acquired by Cheryl Yvonne Grenas were recorded at a stated price of $0.0000 per share. This transaction reflects the conversion of restricted stock units into common stock, rather than an open-market purchase.

What type of security did Cheryl Yvonne Grenas convert into Nutex Health (NUTX) common stock?

Cheryl Yvonne Grenas converted restricted stock units into Nutex Health common stock. According to the disclosure, these restricted stock units convert into common stock on a one-for-one basis, resulting in 603 new common shares credited to her direct holdings.

When did the reported Nutex Health (NUTX) insider transaction by Cheryl Yvonne Grenas occur?

The insider transaction for Cheryl Yvonne Grenas occurred on July 31, 2026. On that date, she acquired 603 shares of Nutex Health common stock through the exercise and conversion of restricted stock units, increasing her total direct ownership to 670 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grenas Cheryl Yvonne

(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.

(Street)
HOUSTON TEXAS 77056

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026M603A$0(1)670D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
/s/ Cheryl Grenas08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)